Movetis

EnteroBiotix

This biopharmaceutical company develops orally administered microbial therapeutics for patients with gastrointestinal diseases, including irritable bowel syndrome and blood cancers.

VectivBio

This company develops biopharmaceutical treatments for severe rare gastrointestinal conditions, including short bowel syndrome, for patients with orphan diseases.

CV Therapeutics

This biopharmaceutical company develops and commercialises small molecule drugs for patients with cardiovascular diseases, including chronic angina and myocardial perfusion imaging needs.

Arvelle Therapeutics

This biopharmaceutical company develops and commercialises antiepileptic medicines to treat patients suffering from central nervous system disorders.

Orphomed

This biopharmaceutical company develops dimer therapeutics for patients suffering from gastrointestinal disorders, including irritable bowel syndrome with diarrhea.

Cinclus Pharma

This biopharmaceutical company develops small molecule drugs for patients suffering from gastric acid-related diseases, including erosive gastroesophageal reflux disease.

Apriwell

This company provides gastrointestinal supplements and a digital therapy app for individuals suffering from chronic constipation and digestive health conditions.

Avexegen

This biopharmaceutical company develops peptide therapies to treat gastrointestinal disorders and restore gut health for patients with inflammatory conditions.